Page last updated: 2024-10-23

bendroflumethiazide and Cancer of Pancreas

bendroflumethiazide has been researched along with Cancer of Pancreas in 2 studies

Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ERNESTI, M1
MITCHELL, ML1
RABEN, MS1
GILBOA, Y1
Perros, P1
Simpson, J1
Innes, JA1
Teale, JD1
McKnight, JA1

Other Studies

2 other studies available for bendroflumethiazide and Cancer of Pancreas

ArticleYear
CONTROL OF HYPOGLYCAEMIA WITH DIAZOXIDE AND HUMAN GROWTH HORMONE.
    Lancet (London, England), 1965, Mar-20, Volume: 1, Issue:7386

    Topics: Adenoma, Islet Cell; Antihypertensive Agents; Bendroflumethiazide; Blood Chemical Analysis; Blood Gl

1965
Non-islet cell tumour-associated hypoglycaemia: 111In-octreotide imaging and efficacy of octreotide, growth hormone and glucocorticosteroids.
    Clinical endocrinology, 1996, Volume: 44, Issue:6

    Topics: Aged; Bendroflumethiazide; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hypoglycemia;

1996